Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kwadwo A. Oduro"'
Autor:
Catherine K. Gestrich, Shanelle J. De Lancy, Adam Kresak, Mohamad G. Sinno, Akua Yalley, Irina Pateva, Howard Meyerson, Shashirekha Shetty, Kwadwo A. Oduro
Publikováno v:
Human Pathology. 136:75-83
Publikováno v:
Human Pathology. 125:108-116
Monoclonal B-cell lymphocytosis is a clonal B-cell population in the peripheral blood (PB) of5x10ˆ9/L without extramedullary (EM) disease, often with a chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) phenotype. The degree of bone
Autor:
Ramya Gadde, Kwadwo A. Oduro
Publikováno v:
International Journal of Laboratory Hematology.
Autor:
Priyatharsini Nirmalanantham, Ramya Gadde, Chris Ryder, Rose Beck, Howard J. Meyerson, Jennifer M. Yoest, Kwadwo Asare Oduro, Navid Sadri, Ramen Sakhi
Publikováno v:
American Journal of Clinical Pathology. 157:219-230
Objectives To examine flow cytometric (FCM) findings in clonal cytopenia of undetermined significance (CCUS) in relation to variant allele fraction (VAF) and mutation risk. Methods Nine FCM parameters, including 5 FCM metrics (Meyerson-Alayed scoring
Autor:
Shanelle De Lancy, Kwadwo Asare Oduro
Publikováno v:
Blood. 140(21)
Autor:
Erika M. Moore, Kwadwo A. Oduro, Audrey N. Jajosky, Navid Sadri, Howard J. Meyerson, Rose Beck, Nathaniel P Havens
Publikováno v:
American Journal of Clinical Pathology. 156:433-444
Objectives We investigated the usefulness of a custom-designed 31-gene next-generation sequencing (NGS) panel implemented on a routine basis for the evaluation of low-grade lymphoproliferative disorders (LPDs). Methods In total, 147 blood, bone marro
Publikováno v:
International Journal of Surgical Pathology. :106689692311683
Lymphoplasmacytic lymphoma often needs to be differentiated from other B-cell lymphomas with plasmacytic differentiation, especially marginal zone cell lymphoma. Molecular detection of MYD88 p.L265P hotspot mutation supports the diagnosis of lymphopl
Autor:
Audrey N, Jajosky, Anna L, Mitchell, Mahmut, Akgul, Shashirekha, Shetty, Jennifer M, Yoest, Stanton L, Gerson, Navid, Sadri, Kwadwo A, Oduro
Publikováno v:
Genes. 13(4)
Germline disruptive variants in
Autor:
Aliyah R. Sohani, Don W. Coulter, Martha Pacheco, Jennifer L. Burns, Ana C. Xavier, Anita P. Price, Mallory Campbell, Bradford S. Hoppe, Kenneth B. Roberts, Christine M. Smith, Adam J. Bobbey, Emily Walling, Erin M Trovillion, Jeffrey A. Magee, Nicole A. Larrier, Susan M. Hiniker, Stacy Cooper, Kwadwo A. Oduro, Branko Cuglievan, Leidy Isenalumhe, Kara M. Kelly, Vivian Y. Chang, Leslie S. Kersun, Ellen C Benya, Saro H. Armenian, Jamie E. Flerlage, Adam J. Lamble
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(6)
Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guide
Autor:
Audrey N. Jajosky, Anna L. Mitchell, Mahmut Akgul, Shashirekha Shetty, Jennifer M. Yoest, Stanton L. Gerson, Navid Sadri, Kwadwo A. Oduro
Publikováno v:
Genes. 13:591
Germline disruptive variants in Protection of Telomeres 1 (POT1) predispose to a wide variety of cancers, including melanoma, chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, myeloproliferative neoplasms, and glioma. We report the first case of